Image source: The Motley Fool. Feb. 2, 2026 at 5 p.m. ET Call participants Chairman, Chief Executive Officer and President — David Simon President, Leasing and Acquisitions — Eli Simon Chief Financial Officer — Brian McDade Need a quote from a Motley Fool analyst? Email [email protected] Risks David Simon said tariffs have "put more pressure on retailers" and are likely to "end up hurting the smal...
Image source: The Motley Fool. Feb. 2, 2026 at 5 p.m. ET Call participants Chairman, Chief Executive Officer and President — David Simon President, Leasing and Acquisitions — Eli Simon Chief Financial Officer — Brian McDade Need a quote from a Motley Fool analyst? Email [email protected] Risks David Simon said tariffs have "put more pressure on retailers" and are likely to "end up hurting the small guys," with increased caution on tenant credit and expectations of more bankruptcies in 2026 included in budgets. The $100 million investment in Saks Global related to Neiman Marcus was written off at year-end, as confirmed by David Simon. Higher net interest expense of $0.25-$0.30 per share is incorporated in the 2026 FFO guidance, as discussed by Brian McDade. Takeaways Real estate FFO -- $4.8 billion, or $12.73 per share, a record for Simon Property Group SPG 0.05% ) -- $4.8 billion, or $12.73 per share, a record for Fourth-quarter real estate FFO -- $3.49 per share, a 4.2% increase compared to the prior year's fourth quarter. -- $3.49 per share, a 4.2% increase compared to the prior year's fourth quarter. Domestic property NOI growth -- Increased 4.8% for the quarter and 4.4% for the year, according to Brian McDade. -- Increased 4.8% for the quarter and 4.4% for the year, according to Brian McDade. Portfolio NOI growth (constant currency) -- 5.1% for the quarter and 4.7% for the year, combining international and domestic results. -- 5.1% for the quarter and 4.7% for the year, combining international and domestic results. Malls and premium outlets occupancy -- Ended at 96.4% at year-end; Mills assets ended at 99.2% occupancy. -- Ended at 96.4% at year-end; Mills assets ended at 99.2% occupancy. Lease signings -- Over 1,300 leases totaling more than 4.4 million square feet in the quarter; annual total exceeded 4,600 leases for 17 million square feet. -- Over 1,300 leases totaling more than 4.4 million square feet in the quarter; annual total exceeded 4,600 leases for 17...
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Solos Technology Limited has filed a patent infringement lawsuit against Meta Platforms (NasdaqGS:META) and its partners over smart-glasses technology. The complaint targets core technologies used in Meta's smart-glasses platform and seeks financial damages an...
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Solos Technology Limited has filed a patent infringement lawsuit against Meta Platforms (NasdaqGS:META) and its partners over smart-glasses technology. The complaint targets core technologies used in Meta's smart-glasses platform and seeks financial damages and an injunction on further alleged use. The case raises questions about potential impacts on Meta's wearables roadmap and its collaborations in the smart-glasses segment. For you as an investor following NasdaqGS:META, this lawsuit highlights the importance of intellectual property in the wearables and smart-glasses space. Meta has been positioning smart-glasses as part of its broader hardware and mixed reality efforts, an area that many large tech companies are exploring. When disputes reach the level of patent litigation, they can add legal complexity to an already competitive product category. Looking ahead, the key issues to watch include whether the case moves quickly toward settlement or proceeds through a longer court process, and whether any injunction is requested or granted. Outcomes related to licensing, product design changes, or limits on distribution could influence how Meta approaches hardware partnerships and future smart-glasses releases. Stay updated on the most important news stories for Meta Platforms by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Meta Platforms. NasdaqGS:META 1-Year Stock Price Chart Is Meta Platforms financially strong enough to weather the next crisis? Quick Assessment ✅ Price vs Analyst Target : At US$706.41 against a consensus target of US$858.71, the shares sit about 22% below where analysts on average expect them to be. ✅ Simply Wall St Valuation : The stock is assessed as undervalued, trading roughly 32.1% below an estimated fair value. ✅ Recent Momentum: A 30 day...
New York, Feb 2, 2026, 18:17 EST — After-hours AMD shares jumped roughly 4% in after-hours trading, just one day before the company reports its quarterly earnings OpenAI has been in talks with AMD, seeking alternatives to certain Nvidia AI chips, Reuters reported Traders are zeroing in on AMD’s earnings and its outlook for data-center and AI demand Advanced Micro Devices shares climbed roughly 4% ...
New York, Feb 2, 2026, 18:17 EST — After-hours AMD shares jumped roughly 4% in after-hours trading, just one day before the company reports its quarterly earnings OpenAI has been in talks with AMD, seeking alternatives to certain Nvidia AI chips, Reuters reported Traders are zeroing in on AMD’s earnings and its outlook for data-center and AI demand Advanced Micro Devices shares climbed roughly 4% to $246.27 in after-hours trading Monday, extending earlier gains. During the regular session, the stock fluctuated between $229.81 and $253. This matters as AMD approaches its results, with investors eager for signs on whether investment in data centers and AI equipment continues to flow through the chip supply chain. Chip stocks have been volatile, and earnings have become a litmus test for the wider AI sector. AMD plans to release its fiscal fourth-quarter and full-year 2025 earnings after markets close on Feb. 3, with a conference call set for 5 p.m. EST, the company announced. (AMD) Chipmakers pushed U.S. stocks higher on Monday, led by AMD’s 4% jump, as gains spread to peers like Micron Technology amid a rally driven by AI-related demand. “The fundamentals are good and earnings are strong,” said Tim Ghriskey of Ingalls & Snyder. (Reuters) After the close, Reuters reported OpenAI is scouting alternatives to certain Nvidia chips, zeroing in on “inference” — the process of generating responses to user prompts. Sources say OpenAI has explored deals with AMD and startups like Cerebras Systems and Groq. Nvidia maintains that its chips remain the go-to for inference workloads. OpenAI confirmed it still depends on Nvidia for the majority of its inference fleet. CEO Sam Altman noted that customers “put a big premium on speed for coding work.” (Reuters) For AMD, talks with OpenAI bring fresh focus to a rivalry where chip speed, power efficiency, and software backing all weigh heavily. Still, changes in major clients’ purchasing usually surface first in guidance, not revenue. In...
(RTTNews) - The Japan stock market has finished lower in two straight sessions, tumbling almost 970 points or 2.7 percent along the way. The Nikkei 225 now sits just above the 37,470-point plateau although it may stop the bleeding on Tuesday. The global forecast for the Asian markets is cautiously optimistic on optimism over the outlook for interest rates. The European markets were slightly lower ...
(RTTNews) - The Japan stock market has finished lower in two straight sessions, tumbling almost 970 points or 2.7 percent along the way. The Nikkei 225 now sits just above the 37,470-point plateau although it may stop the bleeding on Tuesday. The global forecast for the Asian markets is cautiously optimistic on optimism over the outlook for interest rates. The European markets were slightly lower and the U.S. bourses were slightly higher and the Asian markets are tipped to follow the latter lead. The Nikkei finished sharply lower on Monday following losses from the financial shares, technology stocks and automobile producers. For the day, the index plunged 494.43 points or 1.30 percent to finish at 37,470.67 after trading between 37,320.72 and 37,651.18. Among the actives, Nissan Motor shed 0.60 percent, while Mazda Motor plunged 3.41 percent, Toyota Motor stumbled 2.82 percent, Honda Motor surrendered 2.11 percent, Softbank Group cratered 3.40 percent, Mitsubishi UFJ Financial retreated 1.75 percent, Mizuho Financial dropped 0.92 percent, Sumitomo Mitsui Financial skidded 1.08 percent, Mitsubishi Electric sank 0.83 percent, Sony Group dipped 0.21 percent, Panasonic Holdings tumbled 1.98 percent and Hitachi slumped 1.68 percent. The lead from Wall Street is mildly positive as the major averages spent most of Monday in the red before a late rally nudged them over the unchanged line. The Dow added 35.41 points or 0.08 percent to finish at 42,305.48, while the NASDAQ gained 128.85 points or 0.67 percent to close at 19,242.61 and the S&P 500 rose 24.25 points or 0.41 percent to end at 5,935.94. The early weakness on Wall Street reflected renewed trade concerns amid further signs of rising tensions between the U.S. and China. China on Monday pushed back against President Donald Trump's claims that it had broken the Geneva trade agreement, accusing the U.S. of violating the deal with increased tech export restrictions and the revocation of Chinese student visas. However, ...
Microsoft Corporation (NASDAQ:MSFT - Get Free Report)'s stock price dropped 1.6% on Monday . The stock traded as low as $422.25 and last traded at $423.37. Approximately 41,727,276 shares were traded during mid-day trading, an increase of 22% from the average daily volume of 34,120,402 shares. The stock had previously closed at $430.29. Get Microsoft alerts: Sign Up Trending Headlines about Micros...
Microsoft Corporation (NASDAQ:MSFT - Get Free Report)'s stock price dropped 1.6% on Monday . The stock traded as low as $422.25 and last traded at $423.37. Approximately 41,727,276 shares were traded during mid-day trading, an increase of 22% from the average daily volume of 34,120,402 shares. The stock had previously closed at $430.29. Get Microsoft alerts: Sign Up Trending Headlines about Microsoft Here are the key news stories impacting Microsoft this week: Analysts Set New Price Targets A number of research analysts recently commented on the stock. Sanford C. Bernstein reiterated an "outperform" rating and set a $641.00 price objective (down previously from $645.00) on shares of Microsoft in a research note on Thursday. Cantor Fitzgerald restated an "overweight" rating and issued a $590.00 target price on shares of Microsoft in a report on Thursday. Robert W. Baird set a $540.00 price target on shares of Microsoft and gave the company an "outperform" rating in a report on Thursday. DZ Bank reiterated a "buy" rating on shares of Microsoft in a research note on Thursday. Finally, Bank of America lowered their price objective on Microsoft from $640.00 to $520.00 and set a "buy" rating on the stock in a report on Monday, January 26th. One equities research analyst has rated the stock with a Strong Buy rating, forty have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $597.73. View Our Latest Analysis on MSFT Microsoft Stock Performance The company has a market capitalization of $3.14 trillion, a P/E ratio of 26.48, a price-to-earnings-growth ratio of 1.69 and a beta of 1.08. The firm has a 50 day moving average price of $475.83 and a two-hundred day moving average price of $499.62. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.38 and a current ratio of 1.39. Microsoft (NASDAQ:MSFT - Get Free Report) last...
OpenAI isn’t happy with Nvidia’s AI chips anymore, especially when it comes to how fast they can answer users. The company started looking for other options last year, and now it’s talking to AMD, Cerebras, and was even talking to Groq before that got shut down. This tension started getting real when OpenAI realized Nvidia’s chips weren’t fast enough for specific things like writing code and handl...
OpenAI isn’t happy with Nvidia’s AI chips anymore, especially when it comes to how fast they can answer users. The company started looking for other options last year, and now it’s talking to AMD, Cerebras, and was even talking to Groq before that got shut down. This tension started getting real when OpenAI realized Nvidia’s chips weren’t fast enough for specific things like writing code and handling software-to-software tasks. One insider allegedly said OpenAI wants new chips to handle at least 10% of its inference needs going forward. That’s the part where the AI replies to users, not the part where it learns stuff. OpenAI wants faster chips for coding and user replies Most of OpenAI’s current work still runs on Nvidia, but behind the scenes, it’s testing chips that could make everything faster. This includes chips packed with SRAM, which helps speed things up by putting memory right next to the processor. Nvidia and AMD still use memory that sits outside the chip, which slows things down. People inside OpenAI pointed to Codex, the tool that writes code, as the place where the slowness was the biggest problem. Some staff even blamed the weak performance on Nvidia’s hardware. In a press call on January 30, OpenAI CEO Sam Altman said, “Customers using our coding models will put a big premium on speed for coding work.” Sam added that regular ChatGPT users don’t care about speed as much, but for developers and companies, every second counts. He said OpenAI had just signed a deal with Cerebras to help speed things up. At the same time, companies like Anthropic and Google are getting better results using their own chips. Google’s TPUs are built specifically for the kind of work inference needs. That’s made them faster at responding, especially for models like Claude and Gemini. OpenAI-Groq talks shut down after Nvidia license deal OpenAI was also in talks with Groq, another startup building fast chips, but those conversations didn’t go far. Nvidia came in and signed a $...
This commercial-stage biotech develops therapies for B-cell malignancies and autoimmune diseases, leveraging a diverse clinical pipeline. On Feb. 2, Hussman Strategic Advisors, Inc. disclosed in a U.S. Securities and Exchange Commission filing that it sold out its entire position in TG Therapeutics (TGTX 1.05%). Exited 126,000 shares in TG Therapeutics. The stake previously represented 1.0% of fun...
This commercial-stage biotech develops therapies for B-cell malignancies and autoimmune diseases, leveraging a diverse clinical pipeline. On Feb. 2, Hussman Strategic Advisors, Inc. disclosed in a U.S. Securities and Exchange Commission filing that it sold out its entire position in TG Therapeutics (TGTX 1.05%). Exited 126,000 shares in TG Therapeutics. The stake previously represented 1.0% of fund AUM as of the prior quarter What else to know Top holdings after the filing: NASDAQ: QCOM: $4.7 million (1.1% of AUM) NYSE: ETSY: $4.7 million (1.1% of AUM) NYSE: UI: $4.6 million (1.1% of AUM) NYSE: UNFI: $4.2 million (1.0% of AUM) NASDAQ: CHTR: $3.9 million (1.0% of AUM) Company overview Metric Value Revenue (TTM) $531.9 million Net income (TTM) $447.5 million Price (as of market close Jan. 30) $29.43 One-year price change (11.8%) Company snapshot TG Therapeutics is a commercial-stage biotechnology company specializing in innovative therapies for B-cell malignancies and autoimmune diseases. It leverages a diversified pipeline of monoclonal antibodies and small-molecule inhibitors, positioning itself to address unmet needs in hematologic oncology and immunology. With a focus on both development and commercialization, TG Therapeutics aims to expand its market presence through strategic partnerships and a robust clinical program. Its approach combines scientific innovation with targeted market execution to create a competitive edge in the biotechnology sector. Develops and commercializes therapies for B-cell malignancies and autoimmune diseases, with a portfolio including Ublituximab, Umbralisib, Cosibelimab, and several preclinical candidates. Operates a commercial-stage biopharmaceutical business model, generating revenue primarily through the sale and licensing of proprietary drug candidates. Targets healthcare providers and patients in oncology and immunology markets, focusing on hematologic cancers and autoimmune disorders. What this transaction means for investors Pr...
Key Points Hussman Stratgic Advisors sold 126,000 shares of TG Therapeutics. The fund no longer holds any shares. The stake previously represented 1% of fund AUM as of the prior quarter These 10 stocks could mint the next wave of millionaires › On Feb. 2, Hussman Strategic Advisors, Inc. disclosed in a U.S. Securities and Exchange Commission filing that it sold out its entire position in TG Therap...
Key Points Hussman Stratgic Advisors sold 126,000 shares of TG Therapeutics. The fund no longer holds any shares. The stake previously represented 1% of fund AUM as of the prior quarter These 10 stocks could mint the next wave of millionaires › On Feb. 2, Hussman Strategic Advisors, Inc. disclosed in a U.S. Securities and Exchange Commission filing that it sold out its entire position in TG Therapeutics (NASDAQ:TGTX). Exited 126,000 shares in TG Therapeutics. The stake previously represented 1.0% of fund AUM as of the prior quarter What else to know Top holdings after the filing: NASDAQ: QCOM: $4.7 million (1.1% of AUM) NYSE: ETSY: $4.7 million (1.1% of AUM) NYSE: UI: $4.6 million (1.1% of AUM) NYSE: UNFI: $4.2 million (1.0% of AUM) NASDAQ: CHTR: $3.9 million (1.0% of AUM) Company overview Metric Value Revenue (TTM) $531.9 million Net income (TTM) $447.5 million Price (as of market close Jan. 30) $29.43 One-year price change (11.8%) Company snapshot TG Therapeutics is a commercial-stage biotechnology company specializing in innovative therapies for B-cell malignancies and autoimmune diseases. It leverages a diversified pipeline of monoclonal antibodies and small-molecule inhibitors, positioning itself to address unmet needs in hematologic oncology and immunology. With a focus on both development and commercialization, TG Therapeutics aims to expand its market presence through strategic partnerships and a robust clinical program. Its approach combines scientific innovation with targeted market execution to create a competitive edge in the biotechnology sector. Develops and commercializes therapies for B-cell malignancies and autoimmune diseases, with a portfolio including Ublituximab, Umbralisib, Cosibelimab, and several preclinical candidates. Operates a commercial-stage biopharmaceutical business model, generating revenue primarily through the sale and licensing of proprietary drug candidates. Targets healthcare providers and patients in oncology and immunology mar...
It says something about Hong Kong governance when a simple and well-intentioned requirement for bus passengers to buckle up has become yet another embarrassing policy setback involving the executive branch and the revamped Legislative Council. The abrupt U-turn over the new law on seat belts, less than a week after it took effect, might have been one solution to a problematic law. But the blunder ...
It says something about Hong Kong governance when a simple and well-intentioned requirement for bus passengers to buckle up has become yet another embarrassing policy setback involving the executive branch and the revamped Legislative Council. The abrupt U-turn over the new law on seat belts, less than a week after it took effect, might have been one solution to a problematic law. But the blunder is a blow to the image of the government and of Legco, amid mounting public expectations for better governance. Officials and lawmakers must learn their lesson and get it right when the law is ready for reintroduction following a public consultation. That a straightforward and well-meaning legal amendment seeking to protect public safety has collapsed under the weight of its drafting flaws is to be regretted. Following a deadly bus crash that killed 19 passengers in 2018, the authorities cannot be faulted for wanting to extend the existing seat belt requirement in private vehicles, taxis and minibuses to all public buses. But the public backlash during the implementation last week showed many issues had not been well thought through. And when it emerged that the law actually only covers newly registered buses, there was no alternative but to repeal it. Advertisement The public is entitled to ask what went wrong with the legislative process. The seat belt law was among other traffic amendments passed by the “all patriots” Legco last year. Secretary for Transport and Logistics Mable Chan only said it was “undesirable” when asked why the administration had apparently failed to identify the law’s deficiencies until it was questioned by a former lawmaker in a social media post last week. But the minister stopped short of apologising over the fiasco. Some lawmakers conceded that they had overlooked the technical issues. Under the new governance approach, the revamped “all-patriots” legislature is required to cooperate with the government under the executive-led governance princip...
New York, Feb 2, 2026, 18:15 EST — After-hours Shares of Amazon.com Inc climbed 1.5% in after-hours trading Monday, reaching $242.96. The move extended gains from the regular session as investors turned their attention to the company’s upcoming quarterly earnings report later this week. This report matters now because it offers insight into two drivers behind U.S. tech’s recent moves: cloud demand...
New York, Feb 2, 2026, 18:15 EST — After-hours Shares of Amazon.com Inc climbed 1.5% in after-hours trading Monday, reaching $242.96. The move extended gains from the regular session as investors turned their attention to the company’s upcoming quarterly earnings report later this week. This report matters now because it offers insight into two drivers behind U.S. tech’s recent moves: cloud demand and AI costs. Amazon’s results often act as an informal gauge for corporate IT budgets and the health of consumer spending on discretionary goods. Investors are keeping an eye on capital spending, or “capex,” which covers the cash companies invest in data centers, chips, and other durable equipment. This follows sharp moves in megacap tech stocks tied to guidance and spending updates. The wider market set a positive tone. The S&P 500 gained 0.54% on Monday, nearing its record high, with Alphabet and Amazon rising as investors shifted back into big tech, according to market data. “The fundamentals are good and earnings are strong,” said Tim Ghriskey, senior portfolio strategist at Ingalls & Snyder. (Reuters) Amazon Web Services expanded its SageMaker JumpStart catalog with new AI models like DeepSeek OCR, MiniMax M2.1, and Qwen3-VL-8B-Instruct. The move reflects growing demand for plug-and-play tools that spare customers the hassle of training models from scratch. (Amazon Web Services, Inc.) A fresh workforce alert emerged from Washington. A WARN notice lodged with state officials reveals Amazon is set to cut 2,198 jobs starting April 28 and continuing through June, a report based on the filing said. (Axios) Amazon’s satellite broadband project has asked the Federal Communications Commission for an extension to meet an interim low-Earth orbit deployment milestone, throwing its timeline into fresh doubt. Satellite analyst Tim Farrar noted in a post on X that the request should “quiet any questions” about the program’s future but added it requires a more advanced design to ri...
AMD's AMD stock has had an explosive start to 2026, spiking over +15%, and is now up more than +100% in the last year as it gains share in the AI chip market. With companies seeking alternatives to Nvidia’s NVDA ecosystem, AMD’s rally has been driven by surging demand for its AI accelerators, bullish analyst upgrades, and near-sold-out server CPU capacity — creating a perfect storm of optimism aro...
AMD's AMD stock has had an explosive start to 2026, spiking over +15%, and is now up more than +100% in the last year as it gains share in the AI chip market. With companies seeking alternatives to Nvidia’s NVDA ecosystem, AMD’s rally has been driven by surging demand for its AI accelerators, bullish analyst upgrades, and near-sold-out server CPU capacity — creating a perfect storm of optimism around its revenue outlook. This makes it a worthy topic of whether it's still time to buy, hold, or take profits in AMD stock as its Q4 results approach after-market hours on Tuesday, February 3. Image Source: Zacks Investment Research AMD’s Q4 Expectations Based on Zacks estimates, AMD’s Q4 sales are thought to have increased 26% to $9.67 billion compared to $7.66 billion a year ago. On the bottom line, Q4 EPS is expected at $1.32, a 21% increase from $1.09 per share in the comparative quarter. It's noteworthy that AMD has been able to exceed top and bottom line expectations in each of its last four quarterly reports, posting an average sales and EPS surprise of 4.02% and 2.45%, respectively. Image Source: Zacks Investment Research Furthermore, the Zacks ESP (Expected Surprise Prediction) suggests AMD could once again surpass earnings expectations, with the Most Accurate and recent estimate among Wall Street analysts having Q4 EPS pegged at $1.34 and 2% above the underlying Zacks Consensus (Current Qtr below). Image Source: Zacks Investment Research High Demand for AMD’s AI Accelerators Rounding out fiscal 2025, AMD’s total sales are expected at $34.03 billion, a 32% spike from $25.79 billion in 2024. Plus, FY26 sales are projected to soar another 29% to $43.9 billion. It’s worth noting that analysts are already forecasting AMD’s AI revenue for 2026 to be between $14-$15 billion, driven by its MI355 and MI455 accelerator shipments. The MI355 and MI455 accelerators are next-generation AI and HPC (high-performance computing) GPUs built on AMD’s compute DNA architecture (CDNA)....
Jessica Carter/DigitalVision via Getty Images Taking a bearish position on Chinese equities is easy to describe but often harder to execute in practice. Directly shorting Chinese stocks or indices can involve margin requirements, borrowing constraints, and access issues, especially for retail investors. For investors who want amplified downside exposure to Chinese equities over very short time fra...
Jessica Carter/DigitalVision via Getty Images Taking a bearish position on Chinese equities is easy to describe but often harder to execute in practice. Directly shorting Chinese stocks or indices can involve margin requirements, borrowing constraints, and access issues, especially for retail investors. For investors who want amplified downside exposure to Chinese equities over very short time frames, without having to manage short positions themselves, leveraged inverse ETFs like the Direxion Daily FTSE China Bear 3X Shares ETF ( YANG ) can help you fulfill those investment purposes. Today, I will discuss YANG and give a rundown of the fund that should help you understand the product and when it may be suitable for your use case. YANG's Strategy and Goal YANG's goal is to deliver the daily -300% performance of the FTSE China 50 Index before fees and expenses. This is an index that is made up of 50 of the largest and most liquid Chinese companies trading on the Hong Kong Stock Exchange and includes companies like Tencent, Alibaba, Xiaomi, China Construction Bank, and more. The index's top ten holdings and sector breakdown at the time of writing are as follows: FTSE China 50 Index Top Ten Holdings and Sector Breakdown (Direxion) To put it in simpler terms, YANG will look to offer -3x the daily performance of China's 50 largest and most liquid companies in the opposite direction. For example, for every one basis point that the FTSE China 50 Index falls on a given day, YANG will also rise by three. And for every one basis point that the FTSE China 50 Index rises by, YANG will fall by three. Of course, it should be noted that the fund won't offer these exact performance numbers, but it should be fairly close for each day. To accomplish this, the fund operates using derivative instruments, primarily swap agreements, to deliver inverse exposure. These are essentially contracts where the fund and a third party will exchange cashflows based on set terms. In the case of YANG...
Key Points Joby plans to launch air taxi services with its first vertiport at Dubai International Airport in the first quarter. It's also part of the White House's eVTOL Integration Pilot Program and may begin flights as early as this year. 10 stocks we like better than Joby Aviation › Joby Aviation (NYSE: JOBY) is a leading developer of flying taxis, more formally known as electric vertical take-...
Key Points Joby plans to launch air taxi services with its first vertiport at Dubai International Airport in the first quarter. It's also part of the White House's eVTOL Integration Pilot Program and may begin flights as early as this year. 10 stocks we like better than Joby Aviation › Joby Aviation (NYSE: JOBY) is a leading developer of flying taxis, more formally known as electric vertical take-off and landing (eVTOL) aircraft. These vehicles could potentially change the nature of transportation, allowing people to fly high above the city and skip ahead of the traffic grid below. Joby has big plans for this year, but it also has some work to do before it becomes commercially viable. Here's what investors need to know. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » Joby is making progress in the Dubai and U.S. markets Joby Aviation is working closely with regulators in the United Arab Emirates (UAE) and plans to launch its air taxi services in the region as soon as this year. The eVTOL developer has a six-year exclusive partnership with the Road and Transport Authority to build its first vertiport at Dubai International Airport. The vertiport was roughly 60% complete as of November, and the company expects construction to be completed sometime in the first quarter of this year. Three additional landing sites will be placed at major local landmarks, including the Dubai Mall, Atlantis the Royal, and The American University of Dubai. The company has received permission to fly from local civil aviation authorities and has conducted demonstration flights at the Dubai Airshow. Joby plans to start its first passenger flights in Dubai this year, demonstrating its ability to offer air taxi services and gauging demand for it. In the U.S., Joby has entered the final stage of its certification process known as Type Inspection Authorization. Joby is part of...
New York, February 2, 2026, 18:13 EST — After-hours Palantir shares held steady in late after-hours trading, following a sharp initial reaction to the earnings report. The company reported Q4 revenue up 70% and set 2026 revenue guidance significantly higher than analysts expected. Investors are closely monitoring if soaring U.S. commercial demand can justify the high valuation. Palantir Technologi...
New York, February 2, 2026, 18:13 EST — After-hours Palantir shares held steady in late after-hours trading, following a sharp initial reaction to the earnings report. The company reported Q4 revenue up 70% and set 2026 revenue guidance significantly higher than analysts expected. Investors are closely monitoring if soaring U.S. commercial demand can justify the high valuation. Palantir Technologies Inc. shares edged slightly to $147.76 in late after-hours Monday, following a rollercoaster first response to its quarterly earnings and guidance. The stock ended the regular session up roughly 0.8% at $147.80, but in extended hours it swung between $144 and $161, with volume surpassing 71 million shares. (Yahoo Finance) The print matters for more than just Palantir. It’s become a barometer for how quickly major U.S. institutions are moving from AI pilots to fully operational systems that generate revenue, and whether that spending holds up as tech budgets get squeezed. The timing is tricky for high-multiple software stocks. On every earnings call, investors press the same point: deliver margins, prove cash flow, and skip the vague “platforms” talk. Palantir posted Q4 revenue of $1.407 billion, a 70% jump from the prior year, alongside adjusted EPS of $0.25. The company projects Q1 revenue in a tight range of $1.532 billion to $1.536 billion. For the full year 2026, it expects revenue between $7.182 billion and $7.198 billion, with U.S. commercial revenue surpassing $3.144 billion. CEO Alex C. Karp highlighted Palantir’s “Rule of 40” score at an impressive 127% — a figure combining revenue growth and adjusted operating margin. (SEC) The company reported a 137% jump in U.S. commercial revenue to $507 million, while U.S. government revenue climbed 66% to $570 million for the quarter. It closed 180 deals, each valued at $1 million or more, and recorded a total contract value—representing the potential lifetime value of contracts signed during the period—of $4.262 billion, m...